These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 25196381

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The Quest for a Truly Universal Influenza Vaccine.
    Jang YH, Seong BL.
    Front Cell Infect Microbiol; 2019; 9():344. PubMed ID: 31649895
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein.
    Bliss CM, Nachbagauer R, Mariottini C, Cuevas F, Feser J, Naficy A, Bernstein DI, Guptill J, Walter EB, Berlanda-Scorza F, Innis BL, García-Sastre A, Palese P, Krammer F, Coughlan L.
    EBioMedicine; 2024 Jun; 104():105153. PubMed ID: 38805853
    [Abstract] [Full Text] [Related]

  • 5. A live attenuated H5N2 prime- inactivated H5N1 boost vaccination induces influenza virus hemagglutinin stalk specific antibody responses.
    Kongchanagul A, Samnuan K, Wirachwong P, Surichan S, Puthavathana P, Pitisuttithum P, Boonnak K.
    Vaccine; 2020 Jan 22; 38(4):852-858. PubMed ID: 31708176
    [Abstract] [Full Text] [Related]

  • 6. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model.
    Jacobsen H, Rajendran M, Choi A, Sjursen H, Brokstad KA, Cox RJ, Palese P, Krammer F, Nachbagauer R.
    mBio; 2017 Sep 19; 8(5):. PubMed ID: 28928215
    [Abstract] [Full Text] [Related]

  • 7. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
    Liu WC, Nachbagauer R, Stadlbauer D, Solórzano A, Berlanda-Scorza F, García-Sastre A, Palese P, Krammer F, Albrecht RA.
    Front Immunol; 2019 Sep 19; 10():756. PubMed ID: 31105689
    [Abstract] [Full Text] [Related]

  • 8. Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.
    Kim EH, Park HJ, Han GY, Song MK, Pereboev A, Hong JS, Chang J, Byun YH, Seong BL, Nguyen HH.
    J Virol; 2014 Sep 01; 88(17):9693-703. PubMed ID: 24920793
    [Abstract] [Full Text] [Related]

  • 9. The Quest for a Universal Flu Vaccine: Headless HA 2.0.
    Krammer F.
    Cell Host Microbe; 2015 Oct 14; 18(4):395-7. PubMed ID: 26468743
    [Abstract] [Full Text] [Related]

  • 10. Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.
    Wheatley AK, Kent SJ.
    Expert Rev Vaccines; 2015 Oct 14; 14(9):1227-39. PubMed ID: 26175180
    [Abstract] [Full Text] [Related]

  • 11. An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice.
    Kim EH, Han GY, Nguyen H.
    Viruses; 2017 Aug 21; 9(8):. PubMed ID: 28825679
    [Abstract] [Full Text] [Related]

  • 12. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
    He W, Mullarkey CE, Duty JA, Moran TM, Palese P, Miller MS.
    J Virol; 2015 Apr 21; 89(7):3610-8. PubMed ID: 25589655
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protective immunity based on the conserved hemagglutinin stalk domain and its prospects for universal influenza vaccine development.
    Khanna M, Sharma S, Kumar B, Rajput R.
    Biomed Res Int; 2014 Apr 21; 2014():546274. PubMed ID: 24982895
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.